Caveolin-1 as a possible target in the treatment for acne.

Exp Dermatol

Department of Internal Medicine, Touchstone Diabetes Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Published: February 2020

Expression of caveolin-1 (Cav-1) is an important pathophysiological factor in acne. Cav-1 strongly interacts with such well-recognized etiopathogenic factors such as hyperseborrhea, follicular hyperkeratinization and pathogenicity of Cutibacterium acnes. Cav-1 is a strong negative regulator of transforming growth factor beta (TGF-β) expression. It acts as a critical determinant of autophagy, which is significantly induced in acne lesions through C. acnes and by absorption of fatty acids. Cav-1 also demonstrates different correlations with the development of innate immunity. We propose that normalization of Cav-1 expression can serve as a target in anti-acne therapy.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995412PMC
http://dx.doi.org/10.1111/exd.14063DOI Listing

Publication Analysis

Top Keywords

cav-1
5
caveolin-1 target
4
target treatment
4
treatment acne
4
acne expression
4
expression caveolin-1
4
caveolin-1 cav-1
4
cav-1 pathophysiological
4
pathophysiological factor
4
factor acne
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!